search
NanoACTIV
Trends
- 1Xenix Medical wins FDA clearance for NanoACTIV spine implant technology▼Xenix Medical Announces FDA Clearance of NanoACTIV™ Surface Technology for Its Riva® Posterior Fixation System
Xenix Medical has received FDA clearance for its NanoACTIV surface technology, which will be used in the company's Riva Posterior Fixation System, a spinal implant platform. The clearance allows the company to market the surface treatment in the United States for its posterior fixation devices. The announcement was carried by orthopedic and spine industry news outlets, where it is being noted by clinicians and industry watchers tracking new implant technologies.